ConductScience.org, home

Paper38802435

In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study.

Angermair S and 11 others. Sci Rep, 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study. Papers, record 38802435. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38802435

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study.
PubMed
Journal
Sci Rep
PubMed
Year
2024
PubMed
Publication types
Journal Article, Multicenter Study
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.17, provisional
iCite
Revised in PubMed
2024-07-18
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Critical IllnessMajor topic
GlucocorticoidsMajor topic
COVID-19Major topic
COVID-19 Drug TreatmentMajor topic
Hospital MortalityMajor topic
Humans
Male
Female
Aged
Middle Aged
Retrospective Studies
Intensive Care Units
Dexamethasone
SARS-CoV-2
Aged, 80 and over

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132678530Dexamethasone in Hospitalized Patients with Covid-19.N Engl J Med2021https://conductscience.org/library/papers/32678530PubMed
233692120Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline.Eur Respir J2021https://conductscience.org/library/papers/33692120PubMed
334172464Steroid use in elderly critically ill COVID-19 patients.Eur Respir J2021https://conductscience.org/library/papers/34172464PubMed
435090528Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients.Crit Care2022https://conductscience.org/library/papers/35090528PubMed
534837648Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial.Pharmacol Rep2022https://conductscience.org/library/papers/34837648PubMed
638320047Meta-Analysis of Glucocorticoids for Covid-19 Patients Not Receiving Oxygen.NEJM Evid2023https://conductscience.org/library/papers/38320047PubMed
732876695Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.JAMA2020https://conductscience.org/library/papers/32876695PubMed
833876268Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis.Intensive Care Med2021https://conductscience.org/library/papers/33876268PubMed
934781004Survival analysis of all critically ill patients with COVID-19 admitted to the main hospital in Mogadishu, Somalia, 30 March-12 June 2020: which interventions are proving effective in fragile states?Int J Infect Dis2022https://conductscience.org/library/papers/34781004PubMed
1036190994Low-dose versus high-dose dexamethasone for hospitalized patients with COVID-19 pneumonia: A randomized clinical trial.PLoS One2022https://conductscience.org/library/papers/36190994PubMed
1133317589Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes.Crit Care2020https://conductscience.org/library/papers/33317589PubMed
1233150472Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS.Intensive Care Med2020https://conductscience.org/library/papers/33150472PubMed
1333728167Intensive Care Resources and 60-Day Survival of Critically-Ill COVID-19 Patients.Cureus2021https://conductscience.org/library/papers/33728167PubMed
1432887691A living WHO guideline on drugs for covid-19BMJ2020https://conductscience.org/library/papers/32887691PubMed
1518762788Genomic and nongenomic effects of glucocorticoids.Nat Clin Pract Rheumatol2008https://conductscience.org/library/papers/18762788PubMed
1628192415Immune regulation by glucocorticoids.Nat Rev Immunol2017https://conductscience.org/library/papers/28192415PubMed
1716490890Corticosteroid use in the intensive care unit: at what cost?Arch Surg2006https://conductscience.org/library/papers/16490890PubMed
1836030796Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents.Lancet Infect Dis2023https://conductscience.org/library/papers/36030796PubMed
1932876697Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.JAMA2020https://conductscience.org/library/papers/32876697PubMed
2032876694Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.JAMA2020https://conductscience.org/library/papers/32876694PubMed

See all 28 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
40465794In-hospital mortality outcomes of favipiravir in patients with moderate to severe COVID-19 infection: An emulated target trial using real-world data from the largest field hospital in Thailand.PLoS One2025https://conductscience.org/library/papers/40465794

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38802435

GET https://conductscience.org/api/papers/v1/38802435/references?page=2